NEWS

Two Swiss jewels in the crown of pharmaceutical subcontracting rank 1st and 6th in the world ranking published by Genetic Engineering & Biotechnology News.  Proof of a booming sector in our canton.

GaDia SA, a Valais-based start-up specializing in the development of diagnostic tests, and HES-SO Valais-Wallis are to collaborate on the development of a new-generation rapid test for the detection of fungal infections such as Invasive Pulmonary Aspergillosis (IPA). This research project is supported by Innosuisse, the Swiss innovation promotion agency, to the tune of CHF 350,000.

Swiss company ten23 health has just announced an increase in capacity for the manufacture of sterile…

Ten23 health, a company based in Basel and on the BioArk in Visp, announces the launch of “quality…

Based at BioArk’s technology site in Monthey and at Monash University in Melbourne, start-up Orio…

Lugaia, an SME based in the Upper Valais and active in the development of sterile packaging solutions…

Co-authored by Frances Verter of the Parent’s Guide to Cord Blood Foundation and Didier Nouziès, CEO of CordSavings, a cord blood bank based at the Monthey technology site, the article describes the “near” failure of one of the world’s largest cord blood banks, Global Cord Blood Corp, in China, and the lessons to be learned.

Last year, The Ark, the Valais Innovation Foundation, supported 107…

After the opening of their Swiss office, Alpha Onco Swiss, through its CEO Edouard Alphandery, tells…